How much does Tasigna (Nilotinib Capsules) Cost& price without insurance in China?
Tasigna® is the commercial brand name of Nilotinib Capsules, a second-generation tyrosine kinase inhibitor (TKI) developed by Novartis. It exerts its anti-tumor activity by selectively inhibiting the BCR-ABL tyrosine kinase, thereby suppressing the proliferation of BCR-ABL-positive leukemic cells.
Main Indications
Treatment of adult patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic or accelerated phase who are resistant to or intolerant of prior therapy including imatinib.
Common Side Effects
Common adverse reactions: Rash, pruritus, nausea, fatigue, headache, constipation, diarrhea, vomiting, myalgia, and elevated liver enzymes.
Laboratory abnormalities: Decreased blood cell counts (anemia, neutropenia, thrombocytopenia), hypophosphatemia, and hyperbilirubinemia.
Severe but manageable risks: QT interval prolongation, cardiovascular events (ischemic heart disease, peripheral arterial occlusive disease), and pancreatitis.
Approval Status in China
Tasigna® (Nilotinib Capsules, 200mg) was officially approved for marketing in China in July 2009. It is currently a prescription drug included in China’s Category B medical insurance.
Buy Tasigna (Nilotinib Capsules) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
